Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Olcegepant in Healthy Volunteers
NCT02198352Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 1998
- Primary completion
- Aug 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in migraine comparing Olcegepant Arm with Placebo Arm (2 arms). Primary endpoints: Number of subjects with adverse events up to 2 months, Number of subjects with clinically significant changes in vital signs and 3 more. Started Jun 1998; status: completed.
02
Drugs
olcegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02198352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198352.